{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T21:48:30Z","timestamp":1769982510573,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1779,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.vaccine.2008.07.040","type":"journal-article","created":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T14:12:17Z","timestamp":1217859137000},"page":"5269-5275","source":"Crossref","is-referenced-by-count":22,"title":["Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-\u03b21"],"prefix":"10.1016","volume":"26","author":[{"given":"Helen A.","family":"Fletcher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansar A.","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara K.","family":"Berthoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna J.","family":"Dunachie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn T.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola C.","family":"Alder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare R.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian V.S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2008.07.040_bib1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"5514","key":"10.1016\/j.vaccine.2008.07.040_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.1058915","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine","volume":"292","author":"Amara","year":"2001","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.vaccine.2008.07.040_bib3","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2006.03.029","article-title":"Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1\u20136 year old children in a malaria endemic area","volume":"24","author":"Bejon","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.07.040_bib4","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1128\/JVI.80.10.4717-4728.2006","volume":"80","author":"Goonetilleke","year":"2006","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.040_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4049\/jimmunol.175.1.599","article-title":"Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity","volume":"175","author":"Hutchings","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.040_bib6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nm881","article-title":"Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans","volume":"9","author":"McConkey","year":"2003","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.040_bib7","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1371\/journal.pmed.0010033","article-title":"A randomised, double-blind, controlled vaccine efficacy trial of DNA\/MVA ME-TRAP against malaria infection in Gambian adults","volume":"1","author":"Moorthy","year":"2004","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.040_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ijc.20569","article-title":"Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence","volume":"113","author":"Smith","year":"2005","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.040_bib9","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.040_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime\u2013boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.040_bib11","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.vaccine.2008.07.040_bib12","doi-asserted-by":"crossref","first-page":"e1052","DOI":"10.1371\/journal.pone.0001052","article-title":"Boosting BCG with recombinant modified vaccinia Ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials","volume":"2","author":"Pathan","year":"2007","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.vaccine.2008.07.040_bib13","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.040_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.07.040_bib15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1084\/jem.191.7.1187","article-title":"Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor","volume":"191","author":"Lucas","year":"2000","journal-title":"J Exp Med"},{"issue":"6397","key":"10.1016\/j.vaccine.2008.07.040_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/359693a0","article-title":"Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease","volume":"359","author":"Shull","year":"1992","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vaccine.2008.07.040_bib17","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.4049\/jimmunol.172.9.5149","article-title":"Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25\u2212 T cells through Foxp3 induction and down-regulation of Smad7","volume":"172","author":"Fantini","year":"2004","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.07.040_bib18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1084\/jem.20042276","article-title":"TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells","volume":"201","author":"Marie","year":"2005","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.040_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2005.08.006","article-title":"Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection","volume":"23","author":"Walther","year":"2005","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.040_bib20","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/eji.200526189","article-title":"Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level","volume":"35","author":"Roncador","year":"2005","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.07.040_bib21","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1128\/IAI.00590-06","article-title":"A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge","volume":"74","author":"Dunachie","year":"2006","journal-title":"Infect Immun"},{"issue":"Pt 4","key":"10.1016\/j.vaccine.2008.07.040_bib22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1099\/vir.0.19701-0","article-title":"A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans","volume":"85","author":"Mwau","year":"2004","journal-title":"J Gen Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2008.07.040_bib23","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1016\/j.vaccine.2005.10.058","article-title":"Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers","volume":"24","author":"Webster","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.040_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","article-title":"Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells","volume":"37","author":"Wang","year":"2007","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.040_bib25","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.175.11.7264","article-title":"Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance","volume":"175","author":"Moore","year":"2005","journal-title":"J Immunol"},{"issue":"23","key":"10.1016\/j.vaccine.2008.07.040_bib26","doi-asserted-by":"crossref","first-page":"13082","DOI":"10.1128\/JVI.78.23.13082-13089.2004","article-title":"CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1","volume":"78","author":"Toka","year":"2004","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.040_bib27","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.4049\/jimmunol.178.11.6931","article-title":"Human resting CD4+ T cells are constitutively inhibited by TGF beta under steady-state conditions","volume":"178","author":"Classen","year":"2007","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.040_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/hmg\/8.1.93","article-title":"Genetic control of the circulating concentration of transforming growth factor type beta1","volume":"8","author":"Grainger","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"6721","key":"10.1016\/j.vaccine.2008.07.040_bib29","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/17826","article-title":"Inhibition of transforming growth factor-beta\/SMAD signalling by the interferon-gamma\/STAT pathway","volume":"397","author":"Ulloa","year":"1999","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vaccine.2008.07.040_bib30","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1073\/pnas.93.8.3193","article-title":"Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production","volume":"93","author":"Hirsch","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.040_bib31","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1086\/315114","article-title":"Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy","volume":"180","author":"Hirsch","year":"1999","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.040_bib32","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1128\/IAI.67.11.5730-5735.1999","article-title":"Interaction of Mycobacterium tuberculosis-induced transforming growth factor beta1 and interleukin-10","volume":"67","author":"Othieno","year":"1999","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.040_bib33","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/511277","article-title":"Immunosuppression during active tuberculosis is characterized by decreased interferon-gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels","volume":"195","author":"Roberts","year":"2007","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.040_bib34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2249.2006.03049.x","article-title":"A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis","volume":"144","author":"Hernandez-Pando","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.07.040_bib35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1164\/rccm.200508-1294OC","article-title":"T cells are expanded in blood and disease sites in patients with tuberculosis","volume":"173","author":"Guyot-Revol","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.040_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2249.2006.03027.x","article-title":"A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis","volume":"144","author":"Ribeiro-Rodrigues","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.07.040_bib37","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1084\/jem.20062105","article-title":"Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis","volume":"204","author":"Scott-Browne","year":"2007","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.040_bib38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1055\/s-2006-925403","article-title":"Increased TNF-alpha and decreased TGF-beta expression in peripheral blood leukocytes after acute myocardial infarction","volume":"38","author":"Kempf","year":"2006","journal-title":"Horm Metab Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08009845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08009845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T12:18:22Z","timestamp":1588853902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08009845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":38,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0264410X08009845"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.07.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}